The cyclooxygenase-2 selective inhibitor NS-398 does not influence trabecular or cortical bone gain resulting from

T Sugiyama1, L B Meakin, G L Galea

  • 1Department of Veterinary Basic Sciences, The Royal Veterinary College, University of London, London, UK. Toshihiro.Sugiyama@bristol.ac.uk

Abstract

Insights

Daily cyclooxygenase-2 (COX-2) inhibition with NS-398 did not affect bone

Area of Science:

  • Bone biology
  • Pharmacology
  • Skeletal adaptation

Background:

  • Prostaglandins mediate early bone cell responses to mechanical stimuli.
  • Cyclooxygenase-2 (COX-2) expression increases with mechanical strain.
  • COX-2 inhibition reduces osteogenic response to single mechanical loading events.

Purpose of the Study:

  • To investigate the long-term effects of COX-2 inhibition on bone remodeling in response to repeated mechanical loading in female mice.
  • To determine if daily COX-2 inhibition impacts adaptive bone changes from mechanical loading.

Main Methods:

  • Female mice received daily injections of NS-398 (a COX-2 inhibitor) or vehicle for two weeks.
  • Skeletal limbs underwent axial mechanical loading on alternate days.
  • Bone architecture was analyzed using micro-computed tomography.

Main Results:

  • In unloaded limbs, NS-398 reduced trabecular number but not cortical bone.
  • In loaded limbs, NS-398 did not alter the increases in trabecular thickness and cortical bone volume.
  • Repeated mechanical loading increased bone mass in control limbs.

Conclusions:

  • Daily pharmacological inhibition of COX-2 does not impede the adaptive response of trabecular or cortical bone to repeated mechanical loading in female mice.
  • These findings suggest that COX-2 inhibition may not impair bone's functional adaptation to physical activity in women.

Related Concept Videos